Articles tagged with “pancreatic-cancer”

Optune Pax: TTFields FDA Approval for Pancreatic Cancer

Review the 2026 FDA approval of Optune Pax (TTFields) for locally advanced pancreatic cancer. Explore PANOVA-3 trial survival data and mechanism of action.

40 min read

4/30/2026

optune pax tumor treating fields ttfields pancreatic cancer lapc panova-3 fda approval medical oncology

Daraxonrasib RAS(ON) Inhibitor: Pancreatic Cancer Results

Analyze the Phase 3 RASolute-302 trial results for daraxonrasib, a novel RAS(ON) inhibitor demonstrating significant survival benefit in pancreatic cancer.

40 min read

4/28/2026

daraxonrasib rmc-6236 pancreatic cancer ras(on) inhibitors kras mutations rasolute-302 targeted therapy oncology clinical trials